Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
WHO initiative signed new licensing agreements on COVID-19 technologies
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…
CDC reported risk assessment summary for SARS CoV-2 sublineage BA.2.86
On Aug. 23, 2023, the CDC announced it had detected a new SARS-CoV-2 variant labeled BA.2.86. CDC was…
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
WHO issued standing recommendations for COVID including Omicron EG.5 variant risk
On Aug. 9, 2023, the World Health Organization (WHO) released standing recommendations for battling COVID-19 and released an…
Scientists developed breath test that rapidly detects COVID-19 virus
On Jul. 31, 2023, scientists at Washington University in St. Louis have developed a breath test that quickly…
JAMA reported excess death rates for Republican and Democratic voters in Florida and Ohio during COVID-19 pandemic
On Jul. 24, 2023, the Journal JAMA reported there is evidence that Republican-leaning counties had higher COVID-19 death…
U.S. FDA approved Vekluryﾮ (Remdesivir) for COVID-19 treatment in patients with Severe renal impairment
On Jul. 14, 2023, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
CDC launched ﾓBridge Access Programﾔ to provide free COVID-19 vaccines to uninsured and underinsured adults
On Jul. 13, 2023, the Centers for Disease Control and Prevention (CDC) announced the launch of the Bridge…
U.S. FDA updated COVID-19 vaccines for use in the U.S. beginning in Fall 2023
On Jun. 16, 2023, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
U.S. FDA permitted marketing of first COVID-19 at-home test using traditional premarket review process
On Jun. 6, 2023, the U.S. FDA granted granted marketing authorization for the Cue COVID-19 Molecular Test. The…
WHO announced simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern
On May 31, 2023, the World Health Organization announced it had assigned simple, easy to say and remember…
Novavax’s Nuvaxovid received positive CHMP opinion for full marketing authorization for prevention of COVID in the EU
On May 26, 2023, Novavax announced that Nuvaxovid (NVX-CoV2373) had been recommended for full Marketing Authorization (MA) for…
U.S. FDA approved Paxlovid, first oral antiviral for treatment of COVID-19 in adults
On May 25, 2023, the U.S. Food and Drug Administration (FDA) approved the oral antiviral Paxlovid (nirmatrelvir tablets…
Large study provided scientists with deeper insight into long COVID symptoms
On May 25, 2023, the National Institutes of Health announced Initial findings from a study of nearly 10,000…
Study found COVID-19 mRNA booster vaccinations in early pregnancy did not increase miscarriage risk
On May 19, 2023, HealthPartners Institute researchers have published new data in JAMA Network Open that shows monovalent…
Obstructive sleep apnea associated with increased risks for long COVID
On May 11, 2023, a National Institutes of Health supported long-term study reported that among people who have…
U.S. Department of Health and Human Services ended the COVID-19 Public Health Emergency
On May 11, 2023, the U.S. Departments of Health and Human Services announced an end of the COVID-19…
World Health Organization ended its declaration of COVID-19 as a global health emergency
On May 5, 2023, the World Health Organization (WHO) ended its declaration of COVID-19 as a global health…
Study raised concerns SARS-CoV-2 evolution outpaces vaccine-generated antibodies
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
U.S. FDA issued Emergency Use Authorization for new COVID-19 Over-the-Counter at-home antigen test
On Apr. 24, 2023, the U.S. FDA authorized Status COVID-19 Antigen Rapid Test for Home Use (manufactured by…
U.S. state-by-state analysis of COVID-19 impact revealed driving forces behind variations in health published in The Lancet
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
U.S. FDA issued EUA for new COVID-19 over-the-counter at-home antigen test
On Apr. 14, 2023, the U.S. FDA issued an emergency use authorization for the Azure Fastep COVID-19 Antigen…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | NIH | Therapeutics | Vaccine
Frequent testing reduced COVID-19 deaths in nursing facilities
On Apr. 4, 2023, National Institutes of Health (NIH) funded research was announced from the University of Rochester…
Antibiotics do not cut death risk in hospitalized patients with viral respiratory illnesses
On Mar. 24. 2023, antibiotics do not reduce the risk of dying in adults hospitalized with COVID-19, the…
Biotechnology | CDC | COVID-19 | Diagnostics | Life Science News | Vaccine
Tuberculosis in the U.S. increased slightly during 2022 although it remained lower than prepandemic years
On Mar. 24, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Tuberculosis (TB) in…
Paxlovid reduced risk of long-term health problems, death from COVID-19
On Mar. 23. 2023, researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs…
Quest Diagnostics announced first-of-its-kind post-COVID-19 panels available
On Mar. 21, 2023, Quest Diagnostics announced that it had introduced two innovative Post-COVID-19 panels. These laboratory tests…
Biotechnology | COVID-19 | NIH | Pharmaceutical | Vaccine
SARS-CoV-2 infection weakens immune-cell response to vaccination
On Mar. 20, 2023, NIH scientists announced that the magnitude and quality of a key immune cellﾒs response…